Earth Science Tech Inc. announced it has established a new sales division to sharpen its focus on CBD for therapeutic and pharmaceutical-grade products.

Leading the division will be Erika Franck, who for several weeks has productively served as the Company's clinical and therapeutics sales director. ETST formed the new sales division in response to increased CBD interest within the medical, holistic and alternative medical communities and among licensed professionals. As head of the division, Ms. Franck will target medical providers, chiropractors, acupuncturists, holistic wellness practitioners and veterinarians, leveraging her years of expertise in the medical field. Prior to joining ETST, Ms. Franck worked in the pharmaceuticals and orthopedics industry for more than 15 years, filling roles in sales, marketing, medical education and biotechnology divisions in both the U.S. and throughout Latin America. While in pharmaceuticals, Ms. Franck worked for Forest Labs, which is currently under Allergan, AstraZeneca and UCB Pharma. Her expertise includes CNS (central nervous system), psychiatry, cardiology, pulmonology, asthmas, allergy and dermatology. While in pharmaceuticals, Ms. Franck launched two new drugs into the medical market: Lexapro, an SSRI, and Benicar, an ARB. Ms. Franck also worked for Zimmer Orthopedics. Her expertise there included hip and knee arthroplasty (primary and revision), upper extremities, trauma and biologics. Her territory included Latin America, where her focus was medical education through didactic and cadaveric training workshops, helping ensure the safe and effective use of Zimmer products. In addition, Ms. Franck helped develop surgical training materials in English, Spanish and Portuguese to service the region and create sales growth, ensure safety and efficacy, and increase positive patient outcomes.